Goldie SJ - Search Results

1

Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.

Andersson KL, Salomon JA, Goldie SJ, Chung RT. Andersson KL, et al. Among authors: goldie sj. Clin Gastroenterol Hepatol. 2008 Dec;6(12):1418-24. doi: 10.1016/j.cgh.2008.08.005. Epub 2008 Aug 19. Clin Gastroenterol Hepatol. 2008. PMID: 18848905 Free PMC article.

2

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance.

Kim JJ, Wright TC, Goldie SJ. Kim JJ, et al. Among authors: goldie sj. JAMA. 2002 May 8;287(18):2382-90. doi: 10.1001/jama.287.18.2382. JAMA. 2002. PMID: 11988059

3

Empirically calibrated model of hepatitis C virus infection in the United States.

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Salomon JA, et al. Among authors: goldie sj. Am J Epidemiol. 2002 Oct 15;156(8):761-73. doi: 10.1093/aje/kwf100. Am J Epidemiol. 2002. PMID: 12370165

4

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.

Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ. Schackman BR, et al. Among authors: goldie sj. Arch Intern Med. 2002 Nov 25;162(21):2478-86. doi: 10.1001/archinte.162.21.2478. Arch Intern Med. 2002. PMID: 12437408

5

Treatment for hepatitis C virus in human immunodeficiency virus-infected patients: clinical benefits and cost-effectiveness.

Kuehne FC, Bethe U, Freedberg K, Goldie SJ. Kuehne FC, et al. Among authors: goldie sj. Arch Intern Med. 2002 Dec 9-23;162(22):2545-56. doi: 10.1001/archinte.162.22.2545. Arch Intern Med. 2002. PMID: 12456226

6

Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ. Salomon JA, et al. Among authors: goldie sj. JAMA. 2003 Jul 9;290(2):228-37. doi: 10.1001/jama.290.2.228. JAMA. 2003. PMID: 12851278

7

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Goldie SJ, Paltiel AD, Weinstein MC, Losina E, Seage GR 3rd, Kimmel AD, Walensky RP, Sax PE, Freedberg KA. Goldie SJ, et al. Am J Med. 2003 Dec 1;115(8):632-41. doi: 10.1016/j.amjmed.2003.07.007. Am J Med. 2003. PMID: 14656616

8

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

Goldie SJ, Kim JJ, Wright TC. Goldie SJ, et al. Obstet Gynecol. 2004 Apr;103(4):619-31. doi: 10.1097/01.AOG.0000120143.50098.c7. Obstet Gynecol. 2004. PMID: 15051550

9

Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

Goldie SJ, Kohli M, Grima D, Weinstein MC, Wright TC, Bosch FX, Franco E. Goldie SJ, et al. J Natl Cancer Inst. 2004 Apr 21;96(8):604-15. doi: 10.1093/jnci/djh104. J Natl Cancer Inst. 2004. PMID: 15100338

10

Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.

Kim JJ, Leung GM, Woo PP, Goldie SJ. Kim JJ, et al. Among authors: goldie sj. J Public Health (Oxf). 2004 Jun;26(2):130-7. doi: 10.1093/pubmed/fdh138. J Public Health (Oxf). 2004. PMID: 15284314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters